サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1753971

冠動脈ステント市場レポート：タイプ別、バイオマテリアル別、デリバリーモード別、エンドユーザー別、地域別、2025年～2033年

Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 142 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.06円
冠動脈ステント市場レポート：タイプ別、バイオマテリアル別、デリバリーモード別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の冠動脈ステント市場規模は2024年に117億米ドルに達しました。今後、IMARC Groupは、2033年には189億米ドルに達し、2025～2033年の成長率（CAGR）は5.18%になると予測しています。同市場は、主に心血管疾患の有病率の上昇、ステント技術の進歩、高齢者人口の増加によって大きな成長を遂げています。新興市場や生体吸収性ステントなどの技術革新が、世界全体の市場成長をさらに後押ししています。

冠動脈ステントステントとは、バルーン血管形成術の後に狭い冠動脈内に導入され、冠動脈の開通を維持するための小型で自己拡張性のある管状の金属製デバイスです。これらのステントは薬剤でコーティングされており、プラークが蓄積して動脈壁が再び狭くなるのを防ぐためにゆっくりと放出されます。また、胸痛や息切れなどの心臓病の症状を緩和し、心臓への血液と酸素の正常な流れを可能にします。冠動脈ステントは低侵襲（MI）であり、回復に要する時間も短いため、世界中で冠動脈バイパス手術よりも支持を集めています。

冠動脈ステント市場の動向：

薬剤溶出ステント（DES）への嗜好の高まり

薬剤溶出ステント（DES）は、ステント留置後の動脈の再狭窄である再狭窄を減少させる効果があるため、ベアメタルステント（BMS）よりも好ましい選択肢になりつつあります。これらのステントは、動脈内の瘢痕組織の形成を防ぐためにゆっくりと放出される薬剤でコーティングされており、閉塞のリスクを大幅に低下させる。例えば、2024年5月、AbbottはインドでXIENCE Sierraエベロリムス溶出冠動脈ステントシステムを発表しました。このステントは、動脈の再閉塞を軽減する特殊なコーティングが施されており、課題病変や複雑な病態における有効性が実証されています。これに伴い、DESはBMSと比較して再手術の必要性を減らすことで長期予後を改善することが臨床研究で示されています。冠動脈ステントの市場分析によると、再狭窄と長期合併症の減少という優れた性能により、主にベアメタルステントよりも薬剤溶出ステント（DES）の採用が増加しているため、市場は大きく成長する見込みです。

技術の進歩

冠動脈ステントにおける技術進歩には、役目を終えると溶解する生体吸収性ステントの開発が含まれ、これによって長期間のインプラントが不要になり、ステント後期血栓症などのリスクが軽減されます。例えば、2024年7月、MicroPort Scientific CorporationのFiresorb（R）生体吸収性心臓ステントは、中国の国家医療品監督管理局から承認を得た。このステントは臨床試験で優れた性能を示し、標的病変の失敗や血栓症の発生率が低いです。薬剤コーティングバルーンも革新的な技術であり、永久的なデバイスを残すことなく動脈に直接薬剤を送達します。一般に、複雑な病変や再狭窄リスクの高い患者に理想的です。これらの技術は、長期合併症の減少、血管治癒の促進、冠動脈インターベンションにおけるより個別化された治療オプションの提供により、患者の予後を改善することを目的としています。

老年人口の増加と心血管疾患の増加

世界の老人人口の増加に伴い、心血管疾患、特に冠動脈疾患の有病率は増加傾向にあります。世界保健機関（WHO）が発表した報告書によると、2030年までに6人に1人が60歳以上になり、高齢者は14億人になります。2050年にはこの数は倍の21億人になり、80歳以上の高齢者は4億2,600万人になります。コレステロールの蓄積など加齢に関連した要因で動脈が硬化し狭くなっているため、高齢者が冠動脈インターベンションを必要とするケースが増えています。この高齢者層は心臓疾患にかかりやすいため、血流を回復させ心臓発作などの合併症を予防するための冠動脈ステントに対する需要が高まっています。ステント技術の進歩と高齢患者における安全でより効果的な治療の必要性が相まって、冠動脈ステント市場の成長に大きく寄与しています。この需要は、世界の平均寿命の延長とヘルスケアへのアクセスの改善によってさらに加速しています。

本レポートで扱う主な質問

  • 2024年の世界の冠動脈ステント市場規模は？
  • 2025年から2033年にかけての冠動脈ステント世界市場の予測成長率は？
  • 冠動脈ステントの世界市場を牽引する主要因は何か？
  • 冠動脈ステントの世界市場におけるCOVID-19の影響は？
  • 冠動脈ステントの世界市場におけるタイプ別の区分は？
  • 冠動脈ステントの世界市場におけるバイオマテリアル別の区分は？
  • 冠動脈ステントの世界市場におけるデリバリーモード別の区分は？
  • 冠動脈ステントの世界市場におけるエンドユーザー別の区分は？
  • 冠動脈ステントの世界市場における主要地域は？
  • 冠動脈ステントの世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の冠動脈ステント市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 薬剤溶出ステント（DES）
  • ベアメタル冠動脈ステント
  • 生体吸収性ステント

第7章 市場内訳：バイオマテリアル別

  • 金属バイオマテリアル
  • ポリマーバイオマテリアル
  • 天然バイオマテリアル

第8章 市場内訳：デリバリーモード別

  • バルーン拡張型ステント
  • 自己拡張型ステント

第9章 市場内訳：エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Elixir Medical Corporation
    • Lepu Medical Technology（Beijing）Co. Ltd.
    • Medtronic plc
    • Meril Life Sciences Pvt. Ltd.
    • MicroPort Scientific Corporation
    • Terumo Corporation
    • Translumina GmbH
図表

List of Figures

  • Figure 1: Global: Coronary Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Coronary Stents Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Coronary Stents Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Coronary Stents Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Coronary Stents Market: Breakup by Biomaterial (in %), 2024
  • Figure 6: Global: Coronary Stents Market: Breakup by Mode of Delivery (in %), 2024
  • Figure 7: Global: Coronary Stents Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Coronary Stents Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Coronary Stents (Drug-eluting Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Coronary Stents (Drug-eluting Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Coronary Stents (Bare-metal Coronary Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Coronary Stents (Bare-metal Coronary Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Coronary Stents (Bioabsorbable Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Coronary Stents (Bioabsorbable Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Coronary Stents (Metallic Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Coronary Stents (Metallic Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Coronary Stents (Polymeric Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Coronary Stents (Polymeric Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Coronary Stents (Natural Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Coronary Stents (Natural Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Coronary Stents (Balloon-expandable Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Coronary Stents (Balloon-expandable Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Coronary Stents (Self-expanding Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Coronary Stents (Self-expanding Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Coronary Stents (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Coronary Stents (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Coronary Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Coronary Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Coronary Stents (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Coronary Stents (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: North America: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: North America: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: United States: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: United States: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Canada: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Canada: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Asia-Pacific: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Asia-Pacific: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: China: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: China: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Japan: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Japan: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: India: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: India: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: South Korea: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: South Korea: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Australia: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Australia: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Indonesia: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Indonesia: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Europe: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Europe: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Germany: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Germany: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: France: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: France: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United Kingdom: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United Kingdom: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Italy: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Italy: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Spain: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Spain: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Russia: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Russia: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Latin America: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Latin America: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Brazil: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Brazil: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Mexico: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Mexico: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Middle East and Africa: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Middle East and Africa: Coronary Stents Market: Breakup by Country (in %), 2024
  • Figure 79: Middle East and Africa: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Global: Coronary Stents Industry: SWOT Analysis
  • Figure 81: Global: Coronary Stents Industry: Value Chain Analysis
  • Figure 82: Global: Coronary Stents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Coronary Stents Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Coronary Stents Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Coronary Stents Market Forecast: Breakup by Biomaterial (in Million USD), 2025-2033
  • Table 4: Global: Coronary Stents Market Forecast: Breakup by Mode of Delivery (in Million USD), 2025-2033
  • Table 5: Global: Coronary Stents Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Coronary Stents Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Coronary Stents Market: Competitive Structure
  • Table 8: Global: Coronary Stents Market: Key Players
目次
Product Code: SR112025A6083

The global coronary stents market size reached USD 11.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.18% during 2025-2033. The market is experiencing significant growth mainly driven by the rising prevalence of cardiovascular diseases, advancements in stent technology and a growing elderly population. Emerging markets and technological innovations, such as bioresorbable stents, further propels market growth across the globe.

Coronary stents are small, self-expanding tubular metallic devices introduced inside narrow coronary arteries to keep them open after a balloon angioplasty procedure. These stents are coated with a medication, which is slowly released to prevent the walls of arteries from plaque buildup and re-narrowing. They also alleviate heart disease symptoms, such as chest pain and shortness of breath, and allow normal flow of blood and oxygen to the heart. As they are minimally invasive (MI) and require shorter recovery time, coronary stents are gaining traction over coronary artery bypass surgeries around the world.

Coronary Stents Market Trends:

Rising Preference for Drug-Eluting Stents (DES)

Drug-eluting stents (DES) are becoming the preferred option over bare-metal stents (BMS) due to their effectiveness in reducing restenosis which is the re-narrowing of arteries after stenting. These stents are coated with medication that is slowly released to prevent the formation of scar tissue within the artery, thus significantly lowering the risk of blockages. For instance, in May 2024, Abbott introduced the XIENCE Sierra Everolimus eluting coronary stent system in India offering enhanced stent design with a new delivery system and unique sizes to aid in treating complex cases. The stent features a specialized coating to reduce artery re-blocking and has demonstrated efficacy in challenging lesions and complex conditions. In line with this, clinical studies have shown that DES improves long-term outcomes by reducing the need for repeat procedures compared to BMS. According to coronary stents market analysis, the market is set for significant growth due to the rising adoption of drug-eluting stents (DES) over bare-metal stents mainly driven by their superior performance in reducing restenosis and long-term complications.

Technological Advancements

Technological advancements in coronary stents include the development of bioresorbable stents which dissolve after their job is done, thus eliminating the need for long-term implants and reducing risks like late stent thrombosis. For instance, in July 2024, MicroPort Scientific Corporation's Firesorb(R) bioresorbable cardiac stent gained approval from the National Medical Products Administration in China. The stent has shown exceptional performance in clinical studies, with low rates of target lesion failure and thrombosis. Drug-coated balloons are another innovation that deliver drugs directly to the artery without leaving behind a permanent device generally ideal for complex lesions or patients with higher risks of restenosis. These technologies aim to improve patient outcomes by reducing long-term complications, enhancing vessel healing, and offering more personalized treatment options in coronary interventions.

Growing Geriatric Population and Rise of Cardiovascular Diseases

With the rising global geriatric population, the prevalence of cardiovascular diseases, particularly coronary artery disease, is on the rise. According to the report published by World Health Organization (WHO), by 2030, 1 in 6 people will be over 60 years old, and there will be 1.4 billion older individuals. By 2050, this number will double to 2.1 billion, with 426 million aged 80 or older. As arteries harden and narrow due to age-related factors like cholesterol buildup, elderly individuals are increasingly requiring coronary interventions. The higher susceptibility to heart conditions among this group drives the demand for coronary stents to restore blood flow and prevent complications like heart attacks. Advancements in stent technology combined with the need for safe more effective treatments in older patients, are contributing significantly to the coronary stents market growth. This demand is further fuelled by extended life expectancy and improved access to healthcare globally.

Key Market Segmentation:

Breakup by Type:

  • Drug-eluting Stents
  • Bare-metal Coronary Stents
  • Bioabsorbable Stents

Breakup by Biomaterial:

  • Metallic Biomaterial
  • Polymeric Biomaterial
  • Natural Biomaterial

Breakup by Mode of Delivery:

  • Balloon-expandable Stents
  • Self-expanding Stents

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global coronary stents market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Translumina GmbH

Key Questions Answered in This Report

  • 1.What was the size of the global coronary stents market in 2024?
  • 2.What is the expected growth rate of the global coronary stents market during 2025-2033?
  • 3.What are the key factors driving the global coronary stents market?
  • 4.What has been the impact of COVID-19 on the global coronary stents market?
  • 5.What is the breakup of the global coronary stents market based on the type?
  • 6.What is the breakup of the global coronary stents market based on biomaterial?
  • 7.What is the breakup of the global coronary stents market based on the mode of delivery?
  • 8.What is the breakup of the global coronary stents market based on the end user?
  • 9.What are the key regions in the global coronary stents market?
  • 10.Who are the key players/companies in the global coronary stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Coronary Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Drug-eluting Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bare-metal Coronary Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bioabsorbable Stents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Biomaterial

  • 7.1 Metallic Biomaterial
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymeric Biomaterial
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Natural Biomaterial
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Mode of Delivery

  • 8.1 Balloon-expandable Stents
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Self-expanding Stents
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Biotronik SE & Co. KG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 SWOT Analysis
    • 15.3.4 Boston Scientific Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Elixir Medical Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Lepu Medical Technology (Beijing) Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Meril Life Sciences Pvt. Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 MicroPort Scientific Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Terumo Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Translumina GmbH
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio